A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin From Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox) Using Focused Ultrasound in Patients With Primary or Secondary Liver Tumours
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Liver metastases
- Focus Proof of concept; Therapeutic Use
- Acronyms TARDOX
- 02 Aug 2017 Status changed from active, no longer recruiting to completed.
- 07 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 May 2017.
- 07 Apr 2017 Status changed from recruiting to active, no longer recruiting.